Chemotherapy at the end of life: Up until when?

Clinical and Translational Oncology

Volumn 14, Issue 9, 2012, Pages 667-674

  Ortiz, Jaime Sanz ^a  

^a HOSPITAL UNIVERSITARIO MARQUÉS DE VALDECILLA   (Spain)

Author keywords

Advanced cancer; Aggressive treatments; End of life care; Palliative care; Palliative chemotherapy

Indexed keywords

ANTINEOPLASTIC AGENT;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER MORTALITY; CANCER REGISTRY; CANCER STAGING; COLORECTAL CANCER; END OF LIFE; ESOPHAGUS CANCER; FEMALE; HEAD AND NECK CANCER; HOSPITAL ADMISSION; HUMAN; KIDNEY CANCER; LIFE; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; NEOPLASM; OVARY CANCER; PANCREAS CANCER; PROSTATE CANCER; RETROSPECTIVE STUDY; STOMACH CANCER; UNIVERSITY HOSPITAL; WARD;

AGED; FEMALE; HOME CARE SERVICES; HUMANS; MALE; MIDDLE AGED; NEOPLASMS; PALLIATIVE CARE; RETROSPECTIVE STUDIES; TERMINAL CARE;

EID: 84871226944     PISSN: 1699048X     EISSN: 16993055     Source Type: Journal    
DOI: 10.1007/s12094-012-0847-6     Document Type: Article

References (47)

1. Lorenz KA, Lynn J, Dy SM, Shugarman LR, Wilkinson A, Mularski RA et al (2008) Evidence for improving palliative care at the end of the life: a systematic review. Ann Intern Med 148:147-159
2. Ferlay J, Bray F, Pisani P, Parkin DM (2001) GLOBOCAN 20.00: cancer incidence, mortality and prevalence word wide. Version 1.0. IARC CancerBase N. 5.Lyon IARC Press
3. TM): what's in it for the patient? Oncologist 7(suppl 4):25-30
4. García Jordá E (2010) Cancer in Spain. Clin Transl Oncol 12:158-159
5. Sanz-Ortiz J (2002) Oncología Médica y Cuidados Paliativos. Estudio de campo. VIII Congreso Nacional de Oncología Médica, 6-9 Octubre Hotel Meliá Valencia 2002. Libro de Ponencias: p 121; Sociedad Española de Oncología Médica (SEOM)
6. Jemal A, Siegel R, Ward E, Murray T, Xu J, Smigal C, Thun MJ (2006) Cancer statistic 2006. CA Cancer J Clin 56:106-130
7. Sanz-Ortiz J, Mayorga M, Martín Carnicero A (2010) La autopsia clínica en oncología: está en crisis? Med Clin (Barc). doi:10.1016/j.medcli.2009.11.019
8. Sanz Ortiz J (2003) Nuevas dianas moleculares en la terapia del cáncer Tienen función paliativa? Med Pal (Madrid) 10(4):220-225
9. Murillo RJ, Koeller J (2006) Chemotherapy given near the end or life by community oncologist for advanced non-small cell lung cancer. Oncologist 11:1095-1099
10. Raby B, Pater J, Mackillop W (1995) Does knowledge guide practice? Another look at the management of non-small cell lung cancer. J Clin Oncol 13:1904-1911
11. Silvestri G, Pritchard R, Welch HG (1998) Preferences for chemotherapy in patients with non-small cell lung cancer: descriptive study based scripted interviews. BMJ 317:771-775
12. Kean B, Oh D-Y, Lee S, Kim D-W, Kim MR, Im S-A et al (2008) Aggressiveness of cancer-care near the end-of-life in Korea. Jpn J Clin Oncol 38(5):381-386. doi:10.1093/jjco/hym031
13. Earle CC, Landrum MB, Souza JM, Neville V, Weeks JC, Ayanian JZ et al (2008) Aggressiveness of cancer near the end of life: is it a quality-of-care issue? J Clin Oncol 26:3860-3866
14. Temel JS, Greer JA, Muzikansky A, Gallagher ER, Admane S, Vicki AJ, Constance MD, Craig DB, Juliet J, William FP, Andrew B, Thomas JL (2010) Early palliative care for patients with metastatic non-small-cell lung cancer. N Engl J Med 363(8):733-742
15. Fundación ECO (Fundación para la Excelencia y la Calidad de la Oncología). Alerta de la incidencia de cáncer en menores de 65 años. Valencia 3 Febrero 2011. http://www.fundacioneco.es/images/stories/ ECO/Comunicacion/NoticiasInteres/NdPFundacionECO %20Dia %20Mundial %20Contra %20el %20Cancer %20 2011.pdf
16. GLOBOCAN 2008. http://globocan.iarc.fr/factsheets/cancers/all.asp (último acceso Marzo 2011)
17. Emanuel EJ, Young-Xu Y, Levinsky NG, Gazelle G, Saynina O, Arlene SA (2003) Chemotherapy use among Medicare beneficiaries at the end of life. Ann Intern Med 138:639-643
18. Yun YH, Miyoung K, Sang Min P, Samyong K, Jong Soo C, Ho-Yeong L, Chang Geol L, Youn Seon C, Youn Seon H, Si-Young K, Dae Seog H (2007) Chemotherapy use and associated factors among cancer patients near the end of life. Oncology 72:164-171
19. Hashimoto K, Yonemori K, Katsumata N, Hotchi M, Kouno T, Shimizu C, Tamura K, Ando M, Takeuchi M, Fujiwara Y (2009) Factors that affect the duration of the interval between the completion of palliative chemotherapy and death. Oncologist 14:752-759. http://www.TheOncologist.com
20. Sahm S, Will R, Hommel G (2005) What are cancer patients' preferences about treatment at the end of life, and who should start talking about it? A comparison with healthy people and medical staff. Support Care Cancer 13:206-214
21. Sánchez-Muñoz A, Pérez-Ruiz E, Sáez MI, Trigo JM, Galindo MM, Manzaneque L, Jiménez B, Muros B, Alba E (2011) Limited impact of palliative chemotherapy on survival in advanced solid tumours in patients with poor performance status. Clin Transl Oncol 13(6):426-429
22. Romaní Costa V, López E, Rodríguez Carballeira M, Almagro Mena P (2010) Morir en un hospital de agudos. Análisis de la situación de últimos días. Med Pal (Madrid) 17(4):222-225
23. NCCN Clinical Practice Guidelines in Oncology (2008) Palliative care V.1.2008. Standards of Palliative Care (Pal-1)
24. Huskamp HA, Keating NL, Malin JL, Zaslavsky AM, Weeks JC, Earle CC, Teno JM, Virnig BA, Kahn KL, He Y, Ayanian JZ (2009) Discussion with physicians about hospice among patients with metastatic lung cancer. Arch Intern Med 169:954-962
25. Earle CC, Neville BA, Landrum MB, Ayanian JZ, Block SD, Weeks JC (2004) Trends in aggressiveness of cancer care the end of life. J Clin Oncol 22:315-321
26. Malin JL (2004) Bridging the divide: integrating cancer-directed therapy and palliative care. J Clin Oncol 22:3438-3440
27. National Consensus Project for Quality Palliative Care (2004) Clinical Practice Guidelines for quality palliative care. http://www. nationalconsensusproject.org
28. Cherny NI, Portenoy NK (1994) Sedation in the management of refractory symptoms: guidelines for evaluation and treatment. J Palliat Care 10(2):31-38
29. Porta-Sales J, Núñez Olarte JM, Altisent Trota R, Bisbert Aguilar A, Loncan Vidal P, Muñoz Sánchez D et al (2002) Aspectos éticos de la sedación en cuidados paliativos. Med Pal (Madrid) 9(1):41-46
30. Doyle D (1992) Have we looked beyond the physical and psychosocial? J Pain Symptom Manag 7(5):302-311
31. Sanz Ortiz J, Martín Carnicero A (2009) Desasosiego o "disconfortabilidad": un síntoma refractario en la fase final de la vida? Med Clin (Barc) 132(17):669-670
32. Porta Sales J, Ylla-Catalá Boré A, Estibalez Gil I, Griman Malet A, Lafuerza Torres M, Nabal Vicuña C et al (1994) Estudio multicéntrico catalana-balear sobre la sedación Terminal en Cuidados Paliativos. Med Pal (Madrid) 6(4):153-158
33. Sulmasy DP, Pellegrino ED (1999) The rule of double effect: clearing up the double talk. Arch Intern Med 159:545-550
34. Quill TE, Dresser R, Brock DW (1997) The rule of double effect a critique of its role in end-of-life decision making. N Engl J Med 337:1768-1771
35. Sanz Ortiz J (2008) La sedación paliativa como lex artis en el cuidado del final de la vida. PSICOONCOLOGIA 5(2-3):265-277
36. Alvarado-Cabrero I (2007) La autopsia: Tha muerto? Rev Med Mex Seguro Soc 45(1):1-2
37. Burton JL, Underwood J (2007) Clinical, educational, and epidemiological value of autopsy. Lancet 369(9571):1471-1480
38. Petri CAN (1993) Decrease in the frequency of autopsies in Denmark after the introduction of a new Autopsy Act. Int J Qual Health Care 5:315-318
39. Horowitz RE, Naritoku WY (2007) The autopsy as a performance measure and teaching tool. Human Pathol 38:688-695
40. Skrabanek P (ed) (1999) La ideología de la salud. En: La muerte de la medicina con rostro humano. Diaz Santos S. A. Madrid, pp 1-35
41. Bakitas M, Lyons KD, Hegel MT, Balan S, Brokaw FC, Seville J, Hull JG, Li Z, Tosteson TD, Byock IR, Ahles TA (2009) Effects of palliative care intervention on clinical outcomes in patients with advanced cancer. The project ENEABLE II Randomized Controlled Trial. JAMA 302(7):741-749
42. Thomas JS, Bruce EH (2011) Bending the cost in cancer care. N Engl J Med 364(21):2060-2065
43. Gómez-Batiste X, Tuca A, Porta-Sales J, Amor M, Espinosa J, Borrás JM, De la Mata I, Castellsagué J (2006) Resource consumption and cost of palliative care servicies in Spain: a multicenter prospective study. J Pain Symptom Manage 31(6):522-532
44. Hui D, Elsayem A, De la Cruz M et al (2010) Availability an integration of palliative care at USS cancer centers. JAMA 303:1054-1061
45. Dalal Sh, Palla Sh, Hui D, Li N, Chacko R, Li Zh, Fadul N, Scott Ch, Thorton V, Colman B, Amin Y, Bruera E et al (2011) Association between a name change from palliative to supportive care and the timing of patient referrals at a Comprehensive Cancer Center. Oncologist 16:105-111
46. Sanz Ortiz J (2011) Quimioterapia en la fase final de la vida: Tes compasiva? Med Clin (Barc) 136(8):343-344
47. Cancer care during the last phase of life. ASCO SPECIAL ARTICLE. J Clin Oncol 16:1986-1996